Concord Healthcare Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	459.92	388.31	538.65	472.17	470.51
Revenue Growth (YoY)	18.44%	-27.91%	14.08%	0.35%	182.89%
Cost of Revenue	427.97	455.57	603.71	614.77	517.62
Gross Profit	31.95	-67.26	-65.06	-142.6	-47.11
Selling, General & Admin	186.58	259.36	247.16	274	305.56
Research & Development	28.17	31.18	36.44	41.32	40.38
Other Operating Expenses	-16.75	-3.62	-0.77	-7.76	47
Operating Expenses	219.89	300.34	291.74	327.2	392.93
Operating Income	-187.94	-367.6	-356.79	-469.8	-440.05
Interest Expense	-123.53	-109.27	-108.01	-274.48	-435.31
Interest & Investment Income	-	0.73	7.28	7.79	5.47
Earnings From Equity Investments	-3.82	-1.31	-1.74	-0.22	-0.16
Currency Exchange Gain (Loss)	-	-1.09	-0.04	-0.64	0.56
Other Non Operating Income (Expenses)	5.27	-66.15	26.8	41.68	-
EBT Excluding Unusual Items	-310.02	-544.69	-432.49	-695.67	-869.49
Gain (Loss) on Sale of Investments	-	7.56	-	-	-
Gain (Loss) on Sale of Assets	-	40.07	-	-1.13	29.89
Asset Writedown	-	-0.54	-0.25	-0.77	-
Other Unusual Items	-	11.74	0.14	50.4	3.27
Pretax Income	-310.02	-485.85	-432.59	-647.17	-836.34
Income Tax Expense	-4.23	-1.03	-6.2	-9.95	-5.2
Earnings From Continuing Operations	-305.8	-484.82	-426.39	-637.22	-831.13
Minority Interest in Earnings	49.19	41.6	53.3	95.82	14.54
Net Income	-256.6	-443.22	-373.09	-541.4	-816.59
Net Income to Common	-256.6	-443.22	-373.09	-541.4	-816.59
Shares Outstanding (Basic)	748	715	665	479	-
Shares Outstanding (Diluted)	748	715	665	479	-
Shares Change (YoY)	4.53%	7.64%	38.63%	-	-
EPS (Basic)	-0.34	-0.62	-0.56	-1.13	-
EPS (Diluted)	-0.34	-0.62	-0.56	-1.13	-
Free Cash Flow	-201.18	-500.12	331.31	-175.67	-325.96
Free Cash Flow Per Share	-0.27	-0.70	0.50	-0.37	-
Gross Margin	6.95%	-17.32%	-12.08%	-30.20%	-10.01%
Operating Margin	-40.86%	-94.67%	-66.24%	-99.50%	-93.53%
Profit Margin	-55.79%	-114.14%	-69.26%	-114.66%	-173.56%
Free Cash Flow Margin	-43.74%	-128.80%	61.51%	-37.20%	-69.28%
EBITDA	-63.24	-259.85	-241.21	-355.52	-356.26
EBITDA Margin	-13.75%	-66.92%	-44.78%	-75.29%	-75.72%
D&A For EBITDA	124.7	107.75	115.58	114.29	83.79
EBIT	-187.94	-367.6	-356.79	-469.8	-440.05
EBIT Margin	-40.86%	-94.67%	-66.24%	-99.50%	-93.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.